Tablet for Covid? Trial gets delayed as cases plummet in UK
Premium
(REUTERS)
. Updated: 21 Apr 2021, 04:14 PM IST Bloomberg
Roche Holding AG has run into a speed bump as it seeks to rush a pill for Covid-19 to the market: The U.K.’s aggressive vaccine drive has made it harder to find sick people to test it on
Share Via
Read Full Story
Roche Holding AG has run into a speed bump as it seeks to rush a pill for Covid-19 to the market: The U.K.’s aggressive vaccine drive has made it harder to find sick people to test it on.
URL copied
Major manufacturers of Remdisivir have reduced the price considerably. (Photo for representation only)
The demand for Remdesivir, an injectable medicine, has soared manifold amid skyrocketing coronavirus cases in the country. Amid reports of several states pressing the alarm button over the acute shortage of the key antiviral drug, manufacturers have now decided to reduce the price.Â
Union Minister for Chemicals and Fertilizers DV Sadananda Gowda on Friday said that major manufacturers of Remdisivir have reduced the price considerably. On Govtâs intervention, major manufacturers of Remdesivir have voluntarily reduced its MRP ranging from Rs 5400 to less than Rs 3500 by 15.04.2021. This will support PM @narendramodi s efforts to fight #COVID19, Gowda said in his tweet.